BIO-key International is trading 5.48% down at $2.49 in pre-market on October 19; no new company-specific catalyst was identified. - Shares fell 10.85% to $2.63 on October 16. - The move comes amid continued concern about AI infrastructure debt and technology-sector selling, though U.S. indices were higher pre-market. - The October 13 customer announcement preceded the recent rise and does not explain the current decline.